On August 7, 2025, UnitedHealth Group and Amedisys agreed to a proposed settlement with the Department of Justice (DOJ) that clears the way for approval of their proposed $3.3 billion merger. The settlement, filed with the U.S. District Court for the District of Maryland, requires UnitedHealth and Amedisys to divest certain businesses to alleviate DOJ concerns about the merger being anticompetitive. Wilson Sonsini Goodrich & Rosati’s antitrust and competition practice is advising BrightSpring Health Services, a leading provider of home and community-based health services for complex populations, on the acquisition of more than 115 home health and hospice branches in 19 states from UnitedHealth and Amedisys as part of this divestiture.

Wilson Sonsini’s antitrust team represented BrightSpring in the litigation while simultaneously advocating for the settlement in front of the DOJ. The team includes Maureen Ohlhausen, Michelle Yost Hale, Kimberley Biagioli, Lindsey Edwards, and Miata Eggerly. 

For more information, please see the DOJ’s news release on the settlement. Additional coverage is available from Reuters and Healthcare Dive.